FFPRHC Guidance (April 2004): The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health
Open Access
- 1 April 2004
- journal article
- guideline
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 30 (2), 99-108
- https://doi.org/10.1783/147118904322995474
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- FFPRHC Guidance (January 2004) The Copper Intrauterine Device as Long-term ContraceptionBMJ Sexual & Reproductive Health, 2004
- Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trialThe Lancet, 2000
- Guidelines for monitoring patients taking tamoxifen treatment.Drug Safety, 2000
- Effect of intrauterine device use on cervical shedding of HIV-1 DNAAIDS, 1999
- Complications of use of intrauterine devices among HIV-1-infected womenThe Lancet, 1998
- The effects of tamoxifen treatment on the endometriumFertility and Sterility, 1996
- Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trialContraception, 1994
- Effects of various iuds on the composition of cervical mucusContraception, 1991
- Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Yearsʼ Comparative Experience of Levonorgestrel- and Copper-Releasing Intrauterine DevicesObstetrics & Gynecology, 1991
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUDClinical Endocrinology, 1982